Mersana Therapeutics Daily News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Mersana Therapeutics, Inc (NASDAQ:MRSN) Sees Significant Decline in Short Interest

Mersana Therapeutics, Inc. (NASDAQ:MRSN – Get Free Report) saw a significant drop in short interest during the month of May. As of May 15th, there was short interest totalling 8,990,000 shares, a drop of 17.7% from the April 30th total of 10,920,000 shares. Based on an average trading volume of 2,150,000 shares, the days-to-cover ratio […]

Robertw bairdJpmorgan chase coMerck kgaaAsana biosciencesAcadian asset managementJanssen biotech incRussell investments group ltdMersana therapeutics company profileWalleye tradingMersana therapeutics incPricet rowe associates incMerck kgaVanguard group incMersana therapeuticsGet free reportTruist financial

Mersana Therapeutics, Inc (NASDAQ:MRSN) Given Consensus Recommendation of Moderate Buy by Brokerages

Shares of Mersana Therapeutics, Inc. (NASDAQ:MRSN – Get Free Report) have earned an average rating of “Moderate Buy” from the seven ratings firms that are covering the company, MarketBeat reports. Two analysts have rated the stock with a hold rating and five have given a buy rating to the company. The average 1 year price […]

Robertw bairdVictory capital management incJpmorgan chase coRussell investments group ltdSg americas securitiesNisa investment advisorsMersana therapeutics company profileJanssen biotech incAsana biosciencesMersana therapeutics incMerck kgaaMerck kgaMersana therapeuticsGet free reportCapital managementInvestment advisors

Mersana Therapeutics, Inc (NASDAQ:MRSN) Receives Consensus Recommendation of Moderate Buy from Analysts

Shares of Mersana Therapeutics, Inc. (NASDAQ:MRSN – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the seven ratings firms that are covering the stock, Marketbeat.com reports. Two investment analysts have rated the stock with a hold rating and five have issued a buy rating on the company. The average 12-month price […]

Robertw bairdVictory capital management incJanssen biotech incPricet rowe associates incMersana therapeutics incMerck kgaJpmorgan chase coAsana biosciencesHarbor capital advisors incRussell investments group ltdNisa investment advisorsMerck kgaaMersana therapeuticsGet free reportInvestments groupCapital advisors

Mersana Therapeutics (NASDAQ:MRSN) Posts Quarterly Earnings Results, Beats Expectations By $0 02 EPS

Mersana Therapeutics (NASDAQ:MRSN) Posts Quarterly Earnings Results, Beats Expectations By $0 02 EPS
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Janssen biotech incMerck kgaaMersana therapeutics company profileAsana biosciencesMerck kgaMersana therapeutics incJpmorgan chase coMersana therapeuticsGet free reportJanssen biotechAres tradingMersana therapeutics daily

Mersana Therapeutics Sees Unusually Large Options Volume (NASDAQ:MRSN)

Mersana Therapeutics Sees Unusually Large Options Volume (NASDAQ:MRSN)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Robertw bairdAsana biosciencesMersana therapeutics incHarbor capital advisors incMerck kgaVictory capital management incJanssen biotech incRussell investments group ltdJpmorgan chase coNisa investment advisorsMerck kgaaMersana therapeuticsGet free reportInvestments groupCapital advisorsCapital management